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Purpose. Mutations in the gene encoding the tissue inhibitor of metalloproteinases-3 (TIMP3)
have been shown previously to cause Sorsby's fundus dystrophy, an autosomal-dominant disor-
der characterized by extracellular matrix irregularities in Bruch's membrane. To assess the
involvement of TIMP3 in a variety of other macular dystrophies, the authors have screened
this gene for disease-causing mutations in age-related macular degeneration (AMD), adult
vitelliform macular dystrophy (AVMD), central areolar choroidal dystrophy (CACD), syn-
drome-associated macular dystrophies, cone-rod dystrophy, and a group with unspecified
macular degeneration.
Methods. Single-stranded conformational analysis of the entire coding region was performed
using the polymerase chain reaction and oligonucleotide primers flanking the five exons of
the TIMP3 gene as well as the putative promotor region and a highly conserved fragment of
the 3'-untranslated region. The authors analyzed a total of 217 patients, including 143 patients
with AMD, 28 patients with AVMD, 21 patients with CACD, and 25 patients with other forms
of macular dystrophy.
Results. In the 217 patients analyzed, the authors have identified one sequence alteration (a
G-to-C base change) in the 5'-untranslated region in a patient with AMD. However, the
functional consequences of this mutation are not clear. No other disease-causing mutations
were found. The authors have characterized a frequent intragenic polymorphism in exon 3
of the TIMP3 gene (heterozygosity = 0.57) that will be useful for genetic linkage or allele
sharing analyses or both.
Conclusions. The authors' results suggest that TIMP3 is not a major factor in the cause of
AMD, AVMD, and CACD. Thus far, Sorsby's fundus dystrophy appears to be the only pheno-
type known to be associated with mutations in TIMP3. Invest Ophthalmol Vis Sci.
1997; 38:1054-1059.
JLJespite the continuous success in the mapping of
macular dystrophies to specific subchromosomal re-
gions, thus far only two genes, peripherin-retinal de-
generation slow (RDS) and the tissue inhibitor of me-
talloproteinases-3 (TIMP3), have been identified and
shown to be directly involved in the molecular patho-
genesis of some forms of macular degeneration.
Originally, the peripherin-RDS gene was shown
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to be the cause of a slow form of retinal degeneration
in the RDS mouse.1 Subsequently, mutations in the
homologous human gene were found to be responsi-
ble for a variety of retinal degenerations presenting
with a broad spectrum of clinical phenotypes, includ-
ing autosomal-dominant retinitis pigmentosa,2 retini-
tis punctata albescens,3 adult vitelliform macular
dystrophy (AVMD),4 macular dystrophy,4 and pattern
dystrophy of the fovea.5 The striking clinical heteroge-
neity associated with mutations in' the peripherin-
RDS gene was further underscored by the finding of
a single amino acid deletion at codon 153/154 in a
family in which affected members presented either
with retinitis pigmentosa, pattern dystrophy, or fundus
flavimaculatus.6 At present, the mechanisms underly-
ing the extensive clinical heterogeneity as well as the
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TABLE l. Number of Unrelated Patients Analyzed in TIMP3
According to Diagnosis
Diagnosis
Number of
Patients
Patients With Positive
Family History
Mode of
Inheritance
Age-related macular degeneration
Adult vitelliform macular dystrophy
Central areolar choroidal dystrophy
Unclassified macular degeneration^
Syndromic formsj
Cone-rod degeneration
Total
143
28
21
17
5
3
217
12
3
3
8
5
3
34
Unclear*
AD
AD
AD
AD
AD
TIMP3 = metalloproteinases-3; AD = autosomal dominant.
* In four cases, an additional sibling was affected. In eight cases, the father or mother were affected.
f Patients had unclear chorioretinal dystrophies.
X Including patients with various retinopathies in addition to other phenotypic features.
molecular pathology of the various peripherin-RDS
mutations are not well understood.
One member of the family of tissue inhibitors of
metalloproteinases, TIMP3, was identified as the dis-
ease-causing gene in Sorsby's fundus dystrophy (SFD)7
based on its chromosomal localization to 22ql3.189
and its known functional properties in the homeosta-
sis of the extracellular matrix (ECM).10 The ECM ir-
regularities in Bruch's membrane appear to be one
of the key features in SFD" and precede loss of central
vision caused by choroidal neovascularization or geo-
graphic atrophy.12
Primarily two considerations have prompted us to
investigate the possible involvement of TIMP3 in the
pathogenesis of a variety of macular dystrophies. First,
some phenotypic similarities at the level of the RPE
and Bruch's membrane, in particular between age-
related macular degeneration (AMD) and SFD, have
been noted frequendy.1314 Second, allelic TIMP3 mu-
tations may be responsible for various forms of macu-
lar degeneration similar to the observation of exten-
sive clinical heterogeneity associated with peripherin-
RDS mutations.
MATERIALS AND METHODS
Recruitment of Patients
Ten-milliliter ethylenediaminetetraacetic acid blood
samples were obtained from 217 unrelated outpatients
of primarily German descent, including 143 patients
with AMD, 28 with AVMD, 21 with central areolar
choroidal dystrophy, and 25 with other forms of macu-
lar dystrophies (Table 1). The study was conducted in
accordance with the rules and regulations of the local
ethics committee and approval was granted. The ten-
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FIGURE l. (A) Single-stranded conformational analysis of the 5'-untranslated region fragment
showing a heterozygous mobility shift in age-related macular degeneration (patient 109).
(B) Sequencing of the mutant allele shows a G-to-C transversion at position-270 (numbering
starts with +1 at the first base of the translation initiation codon ATG).
Nucleotide
Position
-274
-270
- 2 6 6
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FIGURE 2. (A) Single-stranded conformational analysis of exon 3 of the metalloproteinase-3
(TIMP3) gene showing three mobility shifts (alleles 1, 2, and 3), each in the homozygous
(patients 90, 103, and 4772) and heterozygous (patients 91, 107, and 94) form. DS =
nondenatured double strand control. (B) Sequence analysis of the allelic variants identified
in exon 3. The T-to-C transition in codon 60 (corresponding to allele 2) and the C-to-T
transition in codon 64, in addition to the codon 60 alteration (corresponding to allele 3),
occur in the third base positions, respectively, and do not affect the codon specificities.
ets of the Declaration of Helsinki were followed. All
patients were informed of the purpose of the study,
and written consent was obtained. In total, 34 patients
disclosed a positive family history, and ophthalmologic
examination of at least one relative of each patient was
performed (Table 1). The ophthalmoscopic diagnosis
was confirmed by fluorescein and indocyanine green
angiography in most cases. In the AMD group, the
average age of the patients was 69.7 years (range, 48
to 91 years). Approximately 16% of the patients with
AMD had early nonexudative signs (RPE changes, soft
confluent drusen) or geographic atrophy, whereas
84% had progressed to an exudative stage of the dis-
ease, which was bilateral in 49. All 28 AVMD probands
analyzed in this study had been tested in the periph-
erin-RDS gene, and five presumably pathogenic alter-
ations were identified in patients with no known family
history of AVMD.15
Mutational Analysis
The DNA was isolated from leukocyte nuclei by stan-
dard extraction methods. Based on the genomic
exon-intron sequences of the TIMP3 gene,16 oligonu-
cleotide primers were designed to polymerase chain
reaction (PCR) amplify the five coding exons of
TIMP3 as well as a 516-bp fragment, including part of
the 5'-untranslated region (UTR) and the potential
promotor region. We also examined an evolutionarily
conserved 130-bp fragment within the 3'-UTR that
shows a significant sequence identity among chicken,
mouse, and human TIMP3.17 The oligonucleotide
primer sequences as well as the conditions for the
PCR amplification of the five coding exons have been
published elsewhere.'8 The 5'-UTR fragment was as-
sessed using primers PR2-F (5'-AGG GGT AGC AGT
TAG CAT TC-3') and PR1-R (5'-AGG AGG AGG AGA
AGC CGT C-3') and an annealing temperature of
56°C. The 3'-UTR fragment was amplified using oligo-
nucleotide primers 3'-TIMP-F (5'-ACC TCA CTT CCC
TCC CTT C-3') and 3'-TIMP-R (5'-GAC AGC ATA
GAC CTT TCT TTA A-3') and an annealing tempera-
ture of 57°C.
To increase sensitivity of the single-stranded con-
formational analysis,'9 the PCR products of exons 1
to 5 were digested with appropriate restriction en-
zymes that generated DNA fragments ranging in size
between 65 bp and 172 bp.18 The 516-bp PCR frag-
ment was digested with Smal, yielding restriction frag-
ments of 228 bp, 194 bp, and 94 bp in size. Five micro-
liters of the 1:5 diluted samples subsequently were
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FIGURE 3. Location of sequence alterations within the metalloproteinase-3 (TIMP3) gene.
Exons are indicated by solid boxes with the respective numbers below. Introns are shown
by thin lines. The varying size of exon 5 is indicated by a hatched box downstream the
termination codon, TGA. The G-to-C transversion identified in age-related macular degener-
ation (patient 109) is located 270 nucleotides upstream of the ATG initiation codon within
the 5'-untranslated region (hatched box). The polymorphic alterations Ti8o~*C and Cig2~*T
(Fig. 2) were identified in exon 3. For completeness, the known Sorsby's fundus dystrophy
mutations are indicated in exon 5 (arrowheads) .7A8'25'27
added to 95% formamide, 5 mM sodium hydroxide,
0.1% xylene cyanol, and 0.1% bromphenol blue. The
samples were heat-denatured for 3 minutes, immedi-
ately placed on ice, and separated electrophoretically
at 4°C in 6% nondenaturing polyacrylamide gels that
were run at two conditions, one with and one without
5% glycerol.
The PCR products corresponding to altered mo-
bility shifts were cloned into the cloning kit (pCR II
vector; TA Cloning Kit; Invitrogen, Leek, The Nether-
lands) . Plasmid DNA of recombinant clones was iso-
lated by the alkaline lysis method20 and sequenced
using the Sequenase Version 2.0 Sequencing Kit
(United States Biochemical, Cleveland, OH) and
primers flanking the cloning site (M13-5:5'-CGC CAG
GGT TTT CCC AGT CAC GAC-3' and M13-6: 5'-AGC
GGA TAA CAA TTT CAC ACA GGA-3') as given in
the manufacturer's protocol.
RESULTS
Single-stranded conformational analysis was used to
assess the TIMP3 gene in a total of 217 patients af-
fected with various macular dystrophies (Table 1).
A mobility shift was seen in the 5'-UTR fragment
in one patient (patient 109) who had an exudative
form of AMD in her left eye at the age of 82 years
(Fig. 1A). Sequence analysis showed that the mobility
shift was caused by a heterozygous G-to-C transversion
at position —270 upstream of the first base of the
initiation codon antithymocyte globulin (numbering
according to material published elsewhere)16 (Fig.
IB). This alteration introduced a novel EagI endonu-
clease restriction site that was used to establish a sim-
ple enzymatic assay to screen for the mutational
change in the remaining 216 patients. Although Eag
I cleaves a 516-bp PCR product into two fragments of
445 pb and 71 bp in the wild-type allele, digestion of
the mutant allele results in three fragments of 445 bp,
44 bp, and 27 bp. The G-to-C transversion was found
exclusively in patient 109.
Single-stranded conformational analysis of exons
1, 2, 4, 5, and the 3'-UTR fragment of the TIMP3
gene showed no further band shifts in the 217 patients
studied.
In exon 3, we identified polymorphic mobility
shifts representing three different alleles (Fig. 2A).
Sequencing of the respective homozygous alleles
showed a silent T-to-C transition in the third position
of codon 60 and a silent C-to-T transition in the third
position of codon 64 (Fig. 2B). Combinations of the
two sequence alterations give rise to the three ob-
served mobility shifts with CAT (codon60). . .TCC (co-
don64) representing allele 1, CAC. . .TCC represent-
ing allele 2, and CAC. . .TCT representing allele 3
(Fig. 2A). The fourth possible combination
CAT. . .TCT (allele 4) was not found in our sample.
The frequencies of the three alleles were determined
separately for each subgroup of patients (Table 2) but
did not differ significantly (x = 8.3 [df = 6]; P =
0.22).
DISCUSSION
Two considerations have led us to analyze the tissue
inhibitor of metalloproteinases-3 in a variety of macu-
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TABLE 2. Frequencies of Polymorphic
Alterations in TIMP3 Exon 3 Listed
Independently for the Various Patient
Subgroups
Subgroup of
Patients
AMD (n =
AVMD (n =
CACD (n =
Others (n =
Total (n =
143)
= 28)
21)
= 25)
217)
Haplotype
Codon 60. . .
Codon 64
It
3§
1
2
3
1
2
3
1
2
3
1
2
3
Number of
Haplotypes
Analyzed
143
126
17
27
24
5
19
16
7
19
26
5
208
192
34
Frequency*
0.5
0.44
0.06
0.48
0.43
0.09
0.45
0.38
0.17
0.38
0.52
0.1
0.48
0.44
0.08
TIMP3 = metalloproteinases-3; AMD = age-related macular
degeneration; AVMD = adult vitelliform macular dystrophy;
CACD = central areolar choroidal dystrophy.
* No significant differences in allele frequencies between
subgroups [x2 = 8.3 (df= 6); P= 0.22].
t CAT. . ,TCC (cDNA sequence according to Apte et al, 1994).
t CAC. . .TCC.
§ CAC. . .TCT.
lar dystrophies. First, mutations in TIMP3 have been
shown to cause SFD, an autosomal-dominant disorder
of the macula with onset in the third or fourth decade
of life.7 In the early stages, SFD is characterized by an
abnormal accumulation of yellowish material within
the inner part of Bruch's membrane" that can be
seen clinically as yellow dots or drusen. Later in life,
sudden loss of central vision may occur either because
of choroidal neovascularization with subretinal hem-
orrhage and the development of a disciform scar or,
in the minority of patients, because of atrophic
changes.12 At present, the physiological consequences
of a dysfunctional TIMP3 in the pathogenesis of SFD
remain unclear, although the abnormal deposition of
the lipofuscin-like material within Bruch's membrane
may be a direct consequence of an imbalance in the
TIMP3-matrix metalloproteinase system. Neverthe-
less, some early morphologic similarities primarily in
the ECM between SFD and other maculopathies, such
as AMD and AVMD, raise the possibility of a common
pathogenic pathway directly or indirectly involving
TIMP3.
Second, genetic heterogeneity seems to be a com-
mon feature in retinal dystrophies. For example, mu-
tations in the genes for the a- and the /3-subunits of
the cyclic guanosine monophosphate phosphodiester-
ase21'22 as well as the a-subunit of the rod cyclic guano-
sine monophosphate-gated channel23 can cause au-
tosomal-recessive RP. In addition, mutations in a sin-
gle gene, such as peripherin-RDS, have been shown
to result in a wide range of phenotypes, including
features of retinitis pigmentosa, retinitis punctata alb-
escens, macular degeneration, or fundus flavimacula-
tus.24
To date, mutations in the TIMP3 gene have been
associated exclusively with the SFD phenotype.7'18'25'26
It appears that only a single type of mutation affecting
the C-terminus of the protein causes the clinical fea-
tures of SFD, because all known mutations have been
identified in exon 5 of the TIMP3 gene and lead to
an additional cysteine residue in the mature protein
(Fig. 3). This raises the possibility that another type
of mutation in TIMP3 qualitatively different from the
known one could result in a clearly distinct phenotype.
Our extensive mutational analyses have shown
only a single base change in one patient with AMD
(Fig. 1). At present, the consequences of this alter-
ation within the 5'-UTR of the TIMP3 gene are un-
known, particularly because mRNA expression cannot
be tested as a result of the unavailability of additional
blood samples. Therefore, it cannot be ruled out that
this alteration represents a rare but silent polymor-
phism. Because no other changes were identified ei-
ther in the putative promotor region nor in the coding
sequences nor in the evolutionarily highly conserved
3'-UTR, we conclude that mutations in the TIMP3
gene are not a major factor in the cause of a significant
portion of AMD, AVMD, and central areolar choroidal
dystrophy. However, our findings do not rule out the
possibility that other genes or gene products essential
for the homeostasis of the extracellular matrix (e.g.,
other metalloproteinases or their inhibitors) may par-
ticipate in the pathogenesis of macular degeneration.
The growing understanding of the biochemical pro-
cesses underlying ECM metabolism and the increasing
knowledge of the genes involved will make it feasible
to evaluate further the role of the ECM in the cause
of macular degenerations.
Key Words
extracellular matrix, macular degeneration, retinal pigment
epithelium, Sorsby's fundus dystrophy, TIMP3
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